Kabipac Glucosado En Cloruro De Sodio

Sodium chloride and glucose monohydrate, the active ingredient in Kabipac Glucosado En Cloruro De Sodio, is an electrolyte solution presented as an injection solution for intravenous use. It helps restore extracellular fluid volume, correct electrolyte imbalances, and provide an energy substrate in patients requiring fluid and electrolyte replacement.

GNH USA supplies Kabipac Glucosado En Cloruro De Sodio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and health‑care institutions worldwide.

Kabipac Glucosado En Cloruro De Sodio is used in clinical situations that require rapid restoration of fluid and electrolyte balance. - Fluid and electrolyte replacement: restores intravascular volume and corrects sodium and glucose deficits. - Hypovolemia: increases circulating blood volume to improve tissue perfusion. - Hypoglycemia: supplies glucose to raise blood sugar levels in acute low‑glucose states.

Kabipac Glucosado En Cloruro De Sodio may be associated with the following adverse reactions.

Common Side Effects: - Hypernatremia: elevated serum sodium levels due to excess sodium load. - Hyperglycemia: transient rise in blood glucose after infusion. - Phlebitis or pain at the infusion site. - Fluid overload: signs of edema or pulmonary congestion. - Electrolyte imbalance: shifts in potassium or chloride levels.

Serious or Rare Side Effects: - Severe hypernatremia leading to neurological symptoms. - Anaphylactic reaction or severe hypersensitivity. - Pulmonary edema or acute heart failure in susceptible patients.

When using Kabipac Glucosado En Cloruro De Sodio, consider the following precautions. - Assess electrolyte status: obtain baseline sodium, chloride, and glucose values before infusion. - Monitor blood glucose: check glucose levels during and after administration, especially in diabetic patients. - Adjust infusion rate in cardiac or renal impairment: avoid rapid volume expansion. - Use aseptic technique: ensure sterile handling to prevent infection. - Avoid in patients with known hypersensitivity to sodium chloride or glucose solutions. - Store at 15-30°C: keep in original packaging, protect from light, and do not freeze.

Kabipac Glucosado En Cloruro De Sodio can interact with other medicines as described below.

Major Interactions (Avoid): - Concurrent hypertonic saline or high‑dose sodium bicarbonate: risk of severe hypernatremia. - High‑dose insulin therapy: may cause rapid glucose shifts and hypoglycemia.

Moderate Interactions (Monitor Closely): - Loop or thiazide diuretics: may exacerbate electrolyte disturbances. - Antihypertensive agents: monitor blood pressure due to volume expansion. - Glycemic‑lowering drugs (e.g., metformin, sulfonylureas): watch for unexpected glucose fluctuations. - Renal replacement therapies: adjust dosing based on fluid balance needs.